Logo of Advanced Oxygen Therapy, Inc. - Oxygen Wound Therapy
  • Engaged Outcomes
  • Solutions
    • Topical Wound Oxygen (TWO2)
      • TWO2 Extremity Chamber
      • TWO2 Multi-Patch
    • NEXA™ NPWT System
    • Instructions for Use
      • USA
        • TWO2 – English
        • TWO2 Multi-Patch English
        • TWO2 – Spanish
        • NEXA System – English
      • International
        • TWO2
        • NEXA System
  • Clinicians
    • TWO2 Extremity Chamber
    • TWO2 Multi-Patch
    • Clinical Evidence
    • Educational Videos
    • Eyes on the Wound
    • FAQs
  • Patients
    • TWO2 Extremity Chamber
    • TWO2 Multi-Patch
    • NEXA™ NPWT System
    • Patient Education
    • TWO2 Testimonials
  • About
    • About Us
    • Partnerships
    • Management Team
    • Scientific Clinical Advisory Board
    • In the News
    • Events
    • Careers
    • Regulatory
  • Investors
    • Regulatory & Other News
    • Corporate Governance
    • Share Price Information
    • Financial Reports & Publications
    • Shareholders
    • Contacts and Advisors
    • Board of Directors
    • Email Alerts
    • AIM Rule 26
  • Contact Us
Cost Effectiveness of Topical Wound Oxygen Therapy for Chronic Diabetic Foot Ulcers

Cost Effectiveness of Topical Wound Oxygen Therapy for Chronic Diabetic Foot Ulcers

by Mary Anne Brigham | Apr 29, 2025 | In The News

AOTI’s Dr. Mike Griffiths on Breakthrough for Diabetic Foot Ulcers and Chronic Wound Care

AOTI’s Dr. Mike Griffiths on Breakthrough for Diabetic Foot Ulcers and Chronic Wound Care

by Mary Anne Brigham | Feb 10, 2025 | In The News

AOTI wins the Best Newcomer Award at the AIM Awards 2024

AOTI wins the Best Newcomer Award at the AIM Awards 2024

by Darron Daly | Oct 10, 2024 | In The News

London Stock Exchange welcomes AOTI, Inc. celebrating its successful listing on AIM

London Stock Exchange welcomes AOTI, Inc. celebrating its successful listing on AIM

by Mike Hughes | Aug 19, 2024 | In The News

AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population

AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population

by Mike Hughes | Mar 23, 2022 | In The News, Press

OCEANSIDE, Calif., March 23, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly...
AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population

Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation

by Mike Hughes | Feb 14, 2022 | In The News, Press

OCEANSIDE, Calif., Feb. 14, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of...
Page 1 of 212»
  • Products
  • Healthcare Professionals
  • Professional FAQ
  • Clinical Evidence
  • About Us
  • Careers
  • Contact Us

ABOUT AOTI

We help people with chronic conditions get back to living their lives to the fullest by advancing health equity, access to care, and improving clinical outcomes and quality of life.

  • Follow
  • Follow
  • Follow
Let's Talk

MENU

  • Engaged Outcomes
  • Solutions
  • Clinical Evidence
  • About
  • Careers
  • Contact Us
  • Partnerships

Contact

1-866-HEAL-TWO

General Inquiries

customersupport@aotinc.net

Clinical Support

clinicalsupport@aotinc.net

Copyright ©2025, All Rights Reserved
Mkt-100 Rev. A
  • Cookie Policy
  • Patents
  • Privacy Policy
  • SMS Texting Privacy Policy
  • Regulatory
  • Terms of Service

Copyright ©2025, All Rights Reserved

Mkt-100 Rev. A

  • Cookie Policy
  • Patents
  • Privacy Policy
  • SMS Texting Privacy Policy
  • Regulatory
  • Terms of Service